These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
615 related articles for article (PubMed ID: 31506181)
1. Combined transarterial chemoembolization and radiotherapy as a first-line treatment for hepatocellular carcinoma with macroscopic vascular invasion: Necessity to subclassify Barcelona Clinic Liver Cancer stage C. Kim YJ; Jung J; Joo JH; Kim SY; Kim JH; Lim YS; Lee HC; Kim JH; Yoon SM Radiother Oncol; 2019 Dec; 141():95-100. PubMed ID: 31506181 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Randomized Clinical Trial. Yoon SM; Ryoo BY; Lee SJ; Kim JH; Shin JH; An JH; Lee HC; Lim YS JAMA Oncol; 2018 May; 4(5):661-669. PubMed ID: 29543938 [TBL] [Abstract][Full Text] [Related]
3. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma. Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299 [TBL] [Abstract][Full Text] [Related]
4. Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment. Jun CH; Yoon JH; Cho E; Shin SS; Cho SB; Kim HJ; Park CH; Kim HS; Choi SK; Rew JS Medicine (Baltimore); 2017 Apr; 96(17):e6745. PubMed ID: 28445298 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas. Ni JY; Kong J; Sun HL; Chen YT; Luo JH; Wang WD; Chen D; Jiang XY; Xu LF Acad Radiol; 2018 Apr; 25(4):423-429. PubMed ID: 29198946 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion. Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695 [TBL] [Abstract][Full Text] [Related]
7. Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis . Huang Y; Chen B; Liu N; Li N; Dao H; Chen W; Yang J Int J Clin Pharmacol Ther; 2017 Jun; 55(6):498-508. PubMed ID: 28157070 [TBL] [Abstract][Full Text] [Related]
8. Combined Chemoembolization and Radiotherapy Versus Chemoembolization Alone for Hepatocellular Carcinoma Invading the Hepatic Vein or Inferior Vena Cava. Alrashidi I; Chu HH; Kim JH; Shim JH; Yoon SM; Kim PH; Gwon DI; Ko HK Cardiovasc Intervent Radiol; 2021 Jul; 44(7):1060-1069. PubMed ID: 33745071 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of transarterial chemoembolization for advanced hepatocellular carcinoma between patients with and without extrahepatic metastases. Yoo JJ; Lee JH; Lee SH; Lee M; Lee DH; Cho Y; Lee YB; Yu SJ; Kim HC; Kim YJ; Yoon JH; Kim CY; Lee HS PLoS One; 2014; 9(11):e113926. PubMed ID: 25427152 [TBL] [Abstract][Full Text] [Related]
10. Combined stereotactic body radiotherapy and trans-arterial chemoembolization as initial treatment in BCLC stage B-C hepatocellular carcinoma. Chiang CL; Chan MKH; Yeung CSY; Ho CHM; Lee FAS; Lee VWY; Wong FCS; Blanck O Strahlenther Onkol; 2019 Mar; 195(3):254-264. PubMed ID: 30413833 [TBL] [Abstract][Full Text] [Related]
11. New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization. Kim JH; Shim JH; Lee HC; Sung KB; Ko HK; Ko GY; Gwon DI; Kim JW; Lim YS; Park SH Liver Int; 2017 Dec; 37(12):1861-1868. PubMed ID: 28581250 [TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system. Han K; Kim JH World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959 [TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma. Wu FX; Chen J; Bai T; Zhu SL; Yang TB; Qi LN; Zou L; Li ZH; Ye JZ; Li LQ BMC Cancer; 2017 Sep; 17(1):645. PubMed ID: 28899349 [TBL] [Abstract][Full Text] [Related]
14. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes. Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346 [TBL] [Abstract][Full Text] [Related]
15. Combination of transarterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava tumor thrombus. Koo JE; Kim JH; Lim YS; Park SJ; Won HJ; Sung KB; Suh DJ Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):180-7. PubMed ID: 19926229 [TBL] [Abstract][Full Text] [Related]
16. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion. Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785 [TBL] [Abstract][Full Text] [Related]
17. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681 [TBL] [Abstract][Full Text] [Related]